Literature DB >> 16637918

Immunology of disorders of neuromuscular transmission.

A Vincent1.   

Abstract

The neuromuscular junction (NMJ) is a prototype synapse and myasthenia gravis is the prototypic antibody-mediated disorder. There are now three other disorders of neuromuscular transmission caused by antibodies to other essential components of the NMJ. Antibodies to the muscle-specific kinase, MuSK, are defining a new form of myasthenia that can be associated with muscle atrophy. Antibodies to voltage-gated calcium channels are responsible for muscle weakness and autonomic dysfunction in the Lambert Eaton myasthenic syndrome. Antibodies to voltage-gated potassium channels are found in patients with a range of disorders affecting the NMJ, the autonomic system or the central nervous system. The pathogenic mechanisms probably depend on the IgG subclass of the antibodies and are only partly shared between the diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16637918     DOI: 10.1111/j.1600-0404.2006.00605.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  7 in total

Review 1.  Treatment of myasthenia gravis.

Authors:  Vikas Kumar; Henry J Kaminski
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

2.  Microtransplantation of acetylcholine receptors from normal or denervated rat skeletal muscles to frog oocytes.

Authors:  Annalisa Bernareggi; Jorge Mauricio Reyes-Ruiz; Paola Lorenzon; Fabio Ruzzier; Ricardo Miledi
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

3.  CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis.

Authors:  Jian Rong Sheng; Songhua Quan; Betty Soliven
Journal:  J Immunol       Date:  2014-08-18       Impact factor: 5.422

4.  In vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor.

Authors:  Jian Rong Sheng; Steve Grimme; Palash Bhattacharya; Michael H B Stowell; Michael Artinger; Bellur S Prabahakar; Matthew N Meriggioli
Journal:  Exp Neurol       Date:  2010-07-15       Impact factor: 5.330

5.  Acetylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis?

Authors:  Jian Rong Sheng; Liang Cheng Li; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Muscle Nerve       Date:  2009-08       Impact factor: 3.217

6.  Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen.

Authors:  Mohammad Alimohammadi; Noémie Dubois; Filip Sköldberg; Asa Hallgren; Isabelle Tardivel; Håkan Hedstrand; Jan Haavik; Eystein S Husebye; Jan Gustafsson; Fredrik Rorsman; Antonella Meloni; Christer Janson; Bernard Vialettes; Merja Kajosaari; William Egner; Ravishankar Sargur; Fredrik Pontén; Zahir Amoura; Alain Grimfeld; Filippo De Luca; Corrado Betterle; Jaakko Perheentupa; Olle Kämpe; Jean-Claude Carel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

7.  Autonomic dysfunction detected by skin sympathetic response in Lambert-Eaton myasthenic syndrome: a case report.

Authors:  Jinghong Zhang; Xusheng Huang; Qiang Shi
Journal:  BMC Neurol       Date:  2022-03-19       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.